Integer (NYSE:ITGR) Releases FY 2026 Earnings Guidance

Integer (NYSE:ITGR) updated its FY 2026 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 6.290-6.780 for the period, compared to the consensus estimate of 6.310. The company issued revenue guidance of $1.8 billion-$1.9 billion, compared to the consensus revenue estimate of $1.8 billion.

Analyst Ratings Changes

ITGR has been the topic of a number of recent analyst reports. Wall Street Zen downgraded shares of Integer from a “buy” rating to a “hold” rating in a report on Sunday, January 25th. Piper Sandler lowered their price objective on shares of Integer from $155.00 to $82.00 and set an “overweight” rating on the stock in a research note on Friday, October 24th. Truist Financial upped their target price on shares of Integer from $86.00 to $95.00 and gave the company a “buy” rating in a report on Thursday, December 18th. Argus downgraded Integer from a “buy” rating to a “hold” rating in a research report on Friday, October 24th. Finally, Citigroup raised their price objective on Integer from $69.00 to $75.00 and gave the company a “neutral” rating in a research report on Thursday, December 11th. Four research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $98.38.

Integer Price Performance

Shares of NYSE ITGR opened at $86.67 on Thursday. The business’s 50 day moving average is $82.37 and its 200-day moving average is $88.44. The firm has a market cap of $3.04 billion, a P/E ratio of 36.26, a price-to-earnings-growth ratio of 0.81 and a beta of 0.77. Integer has a 1-year low of $62.00 and a 1-year high of $144.76. The company has a current ratio of 3.71, a quick ratio of 2.45 and a debt-to-equity ratio of 0.70.

Integer declared that its board has approved a share repurchase program on Tuesday, November 4th that allows the company to buyback $200.00 million in outstanding shares. This buyback authorization allows the medical equipment provider to repurchase up to 8.3% of its shares through open market purchases. Shares buyback programs are usually an indication that the company’s board believes its shares are undervalued.

Institutional Investors Weigh In On Integer

A number of large investors have recently added to or reduced their stakes in ITGR. Kestra Advisory Services LLC increased its holdings in Integer by 0.6% in the 4th quarter. Kestra Advisory Services LLC now owns 21,424 shares of the medical equipment provider’s stock worth $1,680,000 after purchasing an additional 136 shares in the last quarter. Orion Porfolio Solutions LLC lifted its stake in shares of Integer by 1.4% in the second quarter. Orion Porfolio Solutions LLC now owns 9,755 shares of the medical equipment provider’s stock worth $1,200,000 after acquiring an additional 138 shares during the period. Lido Advisors LLC lifted its stake in shares of Integer by 5.5% in the fourth quarter. Lido Advisors LLC now owns 2,887 shares of the medical equipment provider’s stock worth $226,000 after acquiring an additional 151 shares during the period. Osaic Holdings Inc. increased its position in Integer by 8.0% during the 2nd quarter. Osaic Holdings Inc. now owns 2,543 shares of the medical equipment provider’s stock valued at $312,000 after purchasing an additional 188 shares during the period. Finally, MML Investors Services LLC grew its holdings in Integer by 2.4% during the 2nd quarter. MML Investors Services LLC now owns 8,222 shares of the medical equipment provider’s stock worth $1,011,000 after acquiring an additional 196 shares during the period. Institutional investors and hedge funds own 99.29% of the company’s stock.

Integer Company Profile

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.